These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1298048)

  • 1. Pharmacokinetics of ranitidine in a homogeneous population of intensive care unit patients during intermittent and continuous administration.
    Geus WP; Vinks AA; Lamers CB
    Scand J Gastroenterol Suppl; 1992; 194():55-8. PubMed ID: 1298048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
    Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
    Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two intravenous ranitidine regimens in a homogeneous population of intensive care unit patients.
    Geus WP; Vinks AA; Smith SJ; Westra P; Lamers CB
    Aliment Pharmacol Ther; 1993 Aug; 7(4):451-7. PubMed ID: 8218759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ranitidine in critically ill infants.
    Wiest DB; O'Neal W; Reigart JR; Brundage RC; Gillette PC; Yost RL
    Dev Pharmacol Ther; 1989; 12(1):7-12. PubMed ID: 2785905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
    Mathôt RA; Geus WP
    Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma aluminum levels during sucralfate prophylaxis for stress ulceration in critically ill patients on continuous venovenous hemofiltration: a randomized, controlled trial.
    Mulla H; Peek G; Upton D; Lin E; Loubani M
    Crit Care Med; 2001 Feb; 29(2):267-71. PubMed ID: 11246304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ranitidine in morbidly obese women.
    Davis RL; Quenzer RW; Bozigian HP; Warner CW
    DICP; 1990 Nov; 24(11):1040-3. PubMed ID: 2275223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ranitidine in geriatric patients with multiple diseases.
    Platt D; Bauer M; Eicher H
    Arch Gerontol Geriatr; 1989 Mar; 8(2):139-50. PubMed ID: 2735786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
    Osteyee JL; Banner W
    Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ranitidine as prophylaxis for gastric stress ulcers in intensive care unit patients: serum concentrations and cost comparisons.
    Pemberton LB; Schaefer N; Goehring L; Gaddis M; Arrighi DA
    Crit Care Med; 1993 Mar; 21(3):339-42. PubMed ID: 8440101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous infusion of ranitidine on intragastric acidity in fasting subjects: comparison with bolus or Gastrojet (pH-stat-adjusted) infusion.
    Thomson AB; Kirdeikis P; Simon K; Zuk L; Pinchbeck B; Wasarab-Rolland D; Kersey K
    Aliment Pharmacol Ther; 1993 Dec; 7(6):649-53. PubMed ID: 8161672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of two ranitidine intravenous infusion regimens in critically ill patients.
    Marchant J; Summers K; McIsaac RL; Wood JR
    Aliment Pharmacol Ther; 1988 Feb; 2(1):55-63. PubMed ID: 2979234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of gastric pH with ranitidine in critically ill patients. Comparison of two intravenous regimens.
    Santucci L; Fiorucci S; Pelli MA; Calderazzo A; Biasini E; Calderazzo PL; Morelli A
    Dig Dis Sci; 1991 May; 36(5):583-7. PubMed ID: 2022159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients.
    Garg DC; Baltodano N; Perez GO; Oster JR; Jallad NS; Weidler DJ
    Pharmacology; 1985; 31(4):189-93. PubMed ID: 4059323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine--bolus or infusion prophylaxis for stress ulcer.
    Böhrer H; Krier C; Jürs G; Warth S
    Crit Care Med; 1989 Apr; 17(4):381-2. PubMed ID: 2702847
    [No Abstract]   [Full Text] [Related]  

  • 19. Twenty-four-hour intragastric pH patterns in ICU patients on ranitidine.
    Moore JG; Clemmer TP; Taylor S; Bishop AL; Maggio S
    Dig Dis Sci; 1992 Dec; 37(12):1802-9. PubMed ID: 1473427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
    Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
    Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.